Formulation for enhanced delivery of phenethylamine
OwnerBruce Kneller, Richard Gaspariinventors
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a formulation comprising phenethylamine or a derivative thereof, and an MAO-B enzyme inhibitor. The present invention is also directed to a method of increasing the absorption of phenethylamine or a derivative thereof, into the bloodstream, cells and tissue. The method includes administering phenethylamine or a derivative thereof, in combination with an MAO-B enzyme inhibitor.
Claims19
A pharmaceutical composition for inhibiting the effects of the enzyme MAO-B wherein the pharmaceutical composition is a DSHEA compliant inhibitor of MAO-B and allows phenylethylamine to reach the brain in sufficient quantities to elucidate a predetermined effect.
A method of increasing the absorption and delaying the metabolism of phenethylamine into/by the bloodstream, cells and tissue comprising administering phenethylamine or a derivative thereof in combination with an MAO-B enzyme inhibitor.
Dependencies are inferred from the claim text.